Pugh, Trevor J TJ; Bell, Jonathan L JL; Bruce, Jeff P JP; Doherty, Gary J GJ; Galvin, Matthew M; Green, Michelle F MF; Hunter-Zinck, Haley H; Kumari, Priti P; Lenoue-Newton, Michele L ML; Li, Marilyn M MM; Lindsay, James J; Mazor, Tali T; Ovalle, Andrea A; Sammut, Stephen-John SJ; Schultz, Nikolaus N; Yu, Thomas V TV; Sweeney, Shawn M SM; Bernard, Brady B; ,
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
George, Suzanne S; von Mehren, Margaret M; Fletcher, Jonathan A JA; Sun, Jichao J; Zhang, Sen S; Pritchard, Justin R JR; Hodgson, John Graeme JG; Kerstein, David D; Rivera, Victor M VM; Haluska, Frank G FG; Heinrich, Michael C MC
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Esteban-Villarrubia, Jorge J; Soto-Castillo, Juan José JJ; Pozas, Javier J; San Román-Gil, María M; Orejana-Martín, Inmaculada I; Torres-Jiménez, Javier J; Carrato, Alfredo A; Alonso-Gordoa, Teresa T; Molina-Cerrillo, Javier J
Phase and context shape the function of composite oncogenic mutations.
Nature
Gorelick, Alexander N AN; Sánchez-Rivera, Francisco J FJ; Cai, Yanyan Y; Bielski, Craig M CM; Biederstedt, Evan E; Jonsson, Philip P; Richards, Allison L AL; Vasan, Neil N; Penson, Alexander V AV; Friedman, Noah D ND; Ho, Yu-Jui YJ; Baslan, Timour T; Bandlamudi, Chaitanya C; Scaltriti, Maurizio M; Schultz, Nikolaus N; Lowe, Scott W SW; Reznik, Ed E; Taylor, Barry S BS
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.
Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs.
Nature
Flavahan, William A WA; Drier, Yotam Y; Johnstone, Sarah E SE; Hemming, Matthew L ML; Tarjan, Daniel R DR; Hegazi, Esmat E; Shareef, Sarah J SJ; Javed, Nauman M NM; Raut, Chandrajit P CP; Eschle, Benjamin K BK; Gokhale, Prafulla C PC; Hornick, Jason L JL; Sicinska, Ewa T ET; Demetri, George D GD; Bernstein, Bradley E BE
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
British Journal Of Cancer
Serrano, César C; Mariño-Enríquez, Adrián A; Tao, Derrick L DL; Ketzer, Julia J; Eilers, Grant G; Zhu, Meijun M; Yu, Channing C; Mannan, Aristotle M AM; Rubin, Brian P BP; Demetri, George D GD; Raut, Chandrajit P CP; Presnell, Ajia A; McKinley, Arin A; Heinrich, Michael C MC; Czaplinski, Jeffrey T JT; Sicinska, Ewa E; Bauer, Sebastian S; George, Suzanne S; Fletcher, Jonathan A JA
Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.
Oncotarget
Na, Young-Soon YS; Ryu, Min-Hee MH; Yoo, Changhoon C; Lee, Ju-Kyung JK; Park, Jung Min JM; Lee, Chae-Won CW; Lee, Sun Young SY; Shin, Young-Kyoung YK; Ku, Ja-Lok JL; Ahn, Sung-Min SM; Kang, Yoon-Koo YK
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17.
Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor.
Cancer Science
Saijo, Ken K; Imai, Hiroo H; Chikamatsu, Sonoko S; Narita, Koichi K; Katoh, Tadashi T; Ishioka, Chikashi C
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations.
Genome Research
Brammeld, Jonathan S JS; Petljak, Mia M; Martincorena, Inigo I; Williams, Steven P SP; Alonso, Luz Garcia LG; Dalmases, Alba A; Bellosillo, Beatriz B; Robles-Espinoza, Carla Daniela CD; Price, Stacey S; Barthorpe, Syd S; Tarpey, Patrick P; Alifrangis, Constantine C; Bignell, Graham G; Vidal, Joana J; Young, Jamie J; Stebbings, Lucy L; Beal, Kathryn K; Stratton, Michael R MR; Saez-Rodriguez, Julio J; Garnett, Mathew M; Montagut, Clara C; Iorio, Francesco F; McDermott, Ultan U
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
Journal Of Translational Medicine
Shi, Eileen E; Chmielecki, Juliann J; Tang, Chih-Min CM; Wang, Kai K; Heinrich, Michael C MC; Kang, Guhyun G; Corless, Christopher L CL; Hong, David D; Fero, Katherine E KE; Murphy, James D JD; Fanta, Paul T PT; Ali, Siraj M SM; De Siena, Martina M; Burgoyne, Adam M AM; Movva, Sujana S; Madlensky, Lisa L; Heestand, Gregory M GM; Trent, Jonathan C JC; Kurzrock, Razelle R; Morosini, Deborah D; Ross, Jeffrey S JS; Harismendy, Olivier O; Sicklick, Jason K JK
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Garner, Andrew P AP; Gozgit, Joseph M JM; Anjum, Rana R; Vodala, Sadanand S; Schrock, Alexa A; Zhou, Tianjun T; Serrano, Cesar C; Eilers, Grant G; Zhu, Meijun M; Ketzer, Julia J; Wardwell, Scott S; Ning, Yaoyu Y; Song, Youngchul Y; Kohlmann, Anna A; Wang, Frank F; Clackson, Tim T; Heinrich, Michael C MC; Fletcher, Jonathan A JA; Bauer, Sebastian S; Rivera, Victor M VM
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors.
British Journal Of Cancer
Bauer, S S; Hilger, R A RA; Mühlenberg, T T; Grabellus, F F; Nagarajah, J J; Hoiczyk, M M; Reichardt, A A; Ahrens, M M; Reichardt, P P; Grunewald, S S; Scheulen, M E ME; Pustowka, A A; Bock, E E; Schuler, M M; Pink, D D
Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
Plos One
Hersmus, Remko R; Stoop, Hans H; van de Geijn, Gert Jan GJ; Eini, Ronak R; Biermann, Katharina K; Oosterhuis, J Wolter JW; Dhooge, Catharina C; Schneider, Dominik T DT; Meijssen, Isabelle C IC; Dinjens, Winand N M WN; Dubbink, Hendrikus Jan HJ; Drop, Stenvert L S SL; Looijenga, Leendert H J LH